Columbia Laboratories Inc. (CBRX) News

News for Columbia Laboratories Inc. (CBRX)

Sector News | Topic News

After Hours: $ 0.78

-0.004 (-0.51%)

Volume: 2.65 k

6:48 PM EST Feb 10, 2012

Thu, Feb 09, 2012

11:00 AM

Faruqi & Faruqi, LLP Announces Investigation of Columbia Laboratories Inc. - PR Newswire

Mon, Feb 06, 2012

3:50 PM

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Columbia Laboratories, Inc. - Business Wire

Thu, Feb 02, 2012

2:57 PM

The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in Columbia Laboratories Inc. of Class Action Lawsuit and the Deadline of April 2, 2012 to Seek a Lead Plaintiff Position - Business Wire

1:56 PM

Robbins Umeda LLP Announces an Investigation of Columbia Laboratories, Inc. - Business Wire

12:40 PM

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Columbia Laboratories, Inc. (NASDAQ: CBRX) - Marketwire

Mon, Jan 23, 2012

1:54 PM

Holzer Holzer & Fistel, LLC Announces Investigation into Columbia Laboratories Inc. - Business Wire

10:43 AM

Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc. - Business Wire

Fri, Jan 20, 2012

4:40 PM

FDA Advisory Committee Declines to Recommend Approval of Progesterone Vaginal Gel 8% for the Reduction of Risk of Preterm Birth in Women with Short Uterine Cervical Length - PR Newswire

Wed, Jan 18, 2012

2:54 PM

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Securities Laws Violations by Columbia Laboratories Inc. - Business Wire

Wed, Dec 14, 2011

6:59 AM

Meta-analysis of Five Clinical Trials including Columbia Laboratories' PREGNANT Study Published in American Journal of Obstetrics and Gynecology - Business Wire

Mon, Nov 14, 2011

10:00 PM

Columbia Laboratories Will Present November 15th at Lazard Capital Markets Healthcare Conference - Business Wire

Thu, Nov 10, 2011

9:48 AM

Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA - PR Newswire

Thu, Sep 22, 2011

9:05 AM

Factors Moving Markets, Worldwide View - Equity Research on Columbia Laboratories Inc. and Accuray Incorporated - Marketwire

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.